---
title: "Scinai tumbles 9% in after-hours trading after 47% intraday surge"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298967640.md"
description: "Scinai falls 9% after hours following a 47% daytime rally as the company exits PinCell deal and targets $5M in 2026 CDMO revenue."
datetime: "2026-09-14T22:25:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298967640.md)
  - [en](https://longbridge.com/en/news/298967640.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298967640.md)
generator: "portal-rs"
---

# Scinai tumbles 9% in after-hours trading after 47% intraday surge

Scinai Immunotherapeutics(SCNI.US) 盘后跌**8.61%**，现报**2.23 美元**。该股在 09/15/2026 常规交易时段大涨**46.99%**，入选当日美股十大涨幅榜，但盘后交易中回吐部分涨幅。

消息面上，公司近期终止了与 PinCell 的 PC111 许可协议，将研发资源重新聚焦于 NanoAb 平台和不断增长的 CDMO 业务。上半年财报显示，公司实现净利润**160 万美元**，主要由**640 万美元**的廉价购买收益驱动。CDMO 业务截至 8 月中旬在手订单达**310 万美元**，管理层预计 2026 年全年 CDMO 收入目标为**500 万美元**。

### Related Stocks

- [SCNI.US](https://longbridge.com/en/quote/SCNI.US.md)

## Related News & Research

- [Scinai Immunotherapeutics Ltd. (SCNI) Secures $5.1M CDMO Work, Runway to Late 2027](https://longbridge.com/en/news/302424934.md)
- [Scinai Immunotherapeutics Extends Cash Runway on New CDMO Deal and October Financing](https://longbridge.com/en/news/302438355.md)
- [Scinai CEO Updates Shareholders on CDMO Growth and Extended Runway Following Completed Financing | SCNI Stock News](https://longbridge.com/en/news/302425019.md)
- [Scinai Immunotherapeutics Secures $4 Million via Private Placement and Warrant Inducement](https://longbridge.com/en/news/301996939.md)
- [Scinai Immunotherapeutics announces private placement raising USD 4 million](https://longbridge.com/en/news/301839290.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**